Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical: Animal study shows Renaparin improves kidney function after transplantation

April 19 (Reuters) - Corline Biomedical AB  CLBIO.ST : 
    * Animal study shows that Renaparin improves kidney function after transplantation 
    * Says pre-clinical study with Renaparin was carried out together with Uppsala University 
and University of Melbourne, Australien 
 
Source text for Eikon:  ID:nHUG3yNSvG  
Further company coverage:  CLBIO.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on Corline Biomedical AB

See all news